logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 5
  • 1
    Griffin, Stephen Douglas
    Born in February 1986
    Individual (1 offspring)
    Officer
    2026-02-01 ~ now
    OF - Director → CIF 0
  • 2
    Darling, Joseph
    Born in December 1957
    Individual (1 offspring)
    Officer
    2019-04-09 ~ 2020-01-29
    OF - Director → CIF 0
  • 3
    Blanchard, Cheryl Renee
    Born in June 1964
    Individual (1 offspring)
    Officer
    2020-01-30 ~ 2026-02-01
    OF - Director → CIF 0
  • 4
    Mcleod, Ian Walter
    Born in August 1965
    Individual (2 offsprings)
    Officer
    2026-02-01 ~ now
    OF - Director → CIF 0
  • 5
    32, Wiggins Avenue, Bedford, United States
    Corporate (1 offspring)
    Person with significant control
    2019-04-09 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

ANIKA THERAPEUTICS LIMITED

Period: 2019-04-09 ~ now
Company number: 11936143
Registered name
ANIKA THERAPEUTICS LIMITED - now
Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Average Number of Employees
72024-01-01 ~ 2024-12-31
92023-01-01 ~ 2023-12-31
Property, Plant & Equipment
23,088 GBP2024-12-31
36,282 GBP2023-12-31
Total Inventories
341,181 GBP2024-12-31
395,519 GBP2023-12-31
Debtors
Current
595,466 GBP2024-12-31
301,485 GBP2023-12-31
Cash at bank and in hand
298,105 GBP2024-12-31
443,925 GBP2023-12-31
Current Assets
1,234,752 GBP2024-12-31
1,140,929 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-794,001 GBP2024-12-31
-783,747 GBP2023-12-31
Net Current Assets/Liabilities
440,751 GBP2024-12-31
357,182 GBP2023-12-31
Total Assets Less Current Liabilities
463,839 GBP2024-12-31
393,464 GBP2023-12-31
Net Assets/Liabilities
463,839 GBP2024-12-31
393,464 GBP2023-12-31
Equity
Called up share capital
1 GBP2024-12-31
1 GBP2023-12-31
1 GBP2023-01-01
Share premium
199,999 GBP2024-12-31
199,999 GBP2023-12-31
199,999 GBP2023-01-01
Retained earnings (accumulated losses)
263,839 GBP2024-12-31
193,464 GBP2023-12-31
123,682 GBP2023-01-01
Equity
463,839 GBP2024-12-31
393,464 GBP2023-12-31
323,682 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
70,375 GBP2024-01-01 ~ 2024-12-31
69,782 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
70,375 GBP2024-01-01 ~ 2024-12-31
69,782 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
70,375 GBP2024-01-01 ~ 2024-12-31
69,782 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
70,375 GBP2024-01-01 ~ 2024-12-31
69,782 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Office equipment
39,580 GBP2024-12-31
39,580 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
3,298 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment, Owned/Freehold
13,194 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
16,492 GBP2024-12-31
Property, Plant & Equipment
Office equipment
23,088 GBP2024-12-31
36,282 GBP2023-12-31
Finished Goods/Goods for Resale
341,181 GBP2024-12-31
395,519 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
86,705 GBP2024-12-31
244,980 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
404,113 GBP2024-12-31
13,802 GBP2023-12-31
Other Debtors
Current
3,850 GBP2023-12-31
Prepayments/Accrued Income
Current
62,133 GBP2024-12-31
Debtors - Deferred Tax Asset
Current
42,515 GBP2024-12-31
38,853 GBP2023-12-31
Trade Creditors/Trade Payables
Current
87,473 GBP2024-12-31
86,596 GBP2023-12-31
Corporation Tax Payable
Current
80,534 GBP2024-12-31
80,266 GBP2023-12-31
Taxation/Social Security Payable
Current
29,157 GBP2024-12-31
44,182 GBP2023-12-31
Other Creditors
Current
203,902 GBP2024-12-31
233,224 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
392,935 GBP2024-12-31
339,479 GBP2023-12-31
Creditors
Current
794,001 GBP2024-12-31
783,747 GBP2023-12-31

  • ANIKA THERAPEUTICS LIMITED
    Info
    Registered number 11936143
    Suite 2, Ground Floor, Templeback,10 Temple Back, Bristol BS1 6FL
    PRIVATE LIMITED COMPANY incorporated on 2019-04-09 (7 years 3 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-04-08
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.